Loading…
Shree Ganesh Remedies (BSE 540737)₹672.35−1.06%Pharmaceuticals
At the end of the Sep 2026 quarter, Shree Ganesh Remedies' shareholders were: promoters 72.84%, DIIs 0.99%, public 26.17%. Promoter holding is unchanged on the quarter. 0.00% of promoter shares were pledged. It had 8,231 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 69.34% | 69.34% | 69.34% | 70.50% | 72.81% | 72.81% | 72.81% | 72.81% | 72.81% | 72.84% | 72.84% | 72.84% |
| FIIs | 0.00% | 0.00% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.01% | 0.00% | 0.00% | 0.00% | 0.00% |
| DIIs | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.52% | 0.99% |
| Public | 30.66% | 30.66% | 30.65% | 29.49% | 27.18% | 27.18% | 27.18% | 27.18% | 27.19% | 27.16% | 26.64% | 26.17% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 7,516 | 7,047 | 7,184 | 8,505 | 8,692 | 8,975 | 9,163 | 8,749 | 8,439 | 8,056 | 7,820 | 8,231 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Chandulal Manubhai Kothia | Promoter | 48.74% | 0.00 |
| Hanshaben Chandubhai Kothia | Promoter | 11.37% | 0.00 |
| Pooja Gunjan Kothia | Promoter | 4.78% | 0.00 |
| Gunjan Chandulal Kothia | Promoter | 3.19% | 0.00 |
| Manubhai Jivabhai Kothiya | Promoter | 1.82% | 0.00 |
| Gunjan Jayantibhai Dhorajiya | Public | 1.70% | −0.01 |
| Hetvi Ketankumar Patel | Promoter | 1.67% | 0.00 |
| V Naga Raja Naidu | Public | 1.26% | 0.00 |
| Parth Chandulal Kothia | Promoter | 1.07% | 0.00 |
| Kothia Ashokkumar Manubhai (Huf) | Promoter | 0.08% | 0.00 |
Promoters held 72.84% of Shree Ganesh Remedies at the end of the Sep 2026 quarter, up 0.03 percentage points from 72.81% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 0.00% (unchanged at 0.00% a quarter earlier) and domestic institutions (DIIs) held 0.99% (up 0.47 percentage points from 0.52% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Shree Ganesh Remedies had 8,231 shareholders at the end of the Sep 2026 quarter, against 8,749 a year earlier.
Gunjan Jayantibhai Dhorajiya (Public) held 1.70% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.